Chemokine-cytokine/treatment | CCL2 | CXCL8 | CCL5 | CXCL(1,2,3) | IL-6 |
---|---|---|---|---|---|
Bb + 10 μM EGFR inhibitor | 1.466b (±0.330) | 0.515 (±0.068) | 0.674 (±0.118) | 0.657b (±0.133) | 0.836b (±0.296) |
Bb + 100 nM PDGFRα/β inhibitor | 1.733 (±0.461 | 0.797 (±0.174) | 0.977 (±0.123) | 0.738 (±0.124) | 0.478 (±0.048) |
Bb + 5 μM FGFR inhibitor | 0.920 (±0.125) | 0.504 (±0.019) | 0.911 (±0.077) | 0.425 (±0.028) | 0.461 (±0.047) |
Bb + 1 μM FGFR inhibitor | 0.753 (±0.165) | 0.670 (±0.047) | 0.573 (±0.081) | 0.652 (±0.043) | 0.706 (±0.082) |
Bb + 500 nM FGFR inhibitor | 0.756 (±0.054) | 0.693 (±0.028) | 0.760 (±0.190) | 0.697 (±0.041) | 0.634 (±0.027) |
Bb + 5 μM src family inhibitor | 1.184 (±0.168) | 1.258 (±0.079) | 1.051 (±0.064) | 0.964 (±0.022) | 1.465 (±0.080) |
Bb + 1 μM src family inhibitor | 0.901 (±0.173) | 0.993b (±0.081) | 0.778 (±0.125) | 1.109 (±0.091) | 1.035 (±0.082) |
Bb + 500 nM src family inhibitor | 0.893 (±0.122) | 0.919 (±0.079) | 0.847 (±0.036) | 1.061 (±0.100) | 1.044 (±0.137) |